Related references
Note: Only part of the references are listed.Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: Primary outcome of the COLOPEC multicenter randomized trial.
Charlotte Emma Louise Klaver et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
PRODIGE 7 should be interpreted with caution
Gabriel Liberale et al.
ACTA CHIRURGICA BELGICA (2019)
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
Wim Ceelen
EJSO (2019)
A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.
Francois Quenet et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-NTC01226394).
Diane Goere et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Short Course Radiation in the Treatment of Localized Rectal cancer: A Systematic Review and Meta-Analysis
Cui Chen et al.
SCIENTIFIC REPORTS (2015)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
